CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-07-01 | KOZARICH JOHN W Director | Sale | −100 | $119.47 | $12K | 42,883 |
| 2016-07-01 | KOZARICH JOHN W Director | Sale | −800 | $121.54 | $97K | 42,083 |
| 2016-07-01 | KOZARICH JOHN W Director | Sale | −100 | $122.23 | $12K | 41,983 |
| 2016-06-30 | Korenberg Matthew E VP, Finance and CFO | Other acquisition | +196 | $87.10 | $17K | 10,066 |
| 2016-06-30 | Herman Melanie J Director of Accounting | Other acquisition | +157 | $87.10 | $14K | 3,454 |
| 2016-06-01 | KOZARICH JOHN W Director | Sale | −900 | $117.19 | $105K | 43,083 |
| 2016-06-01 | KOZARICH JOHN W Director | Sale | −100 | $119.48 | $12K | 42,983 |
| 2016-05-23 | Sabba Stephen L Director | Grant or award | +622 | 27,244 | ||
| 2016-05-23 | Sabba Stephen L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,329 | 2,329 | ||
| 2016-05-23 | Patel Sunil Director | Grant or award | +622 | 38,647 | ||
| 2016-05-23 | Patel Sunil Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,329 | $119.30 | $278K | 2,329 |
| 2016-05-23 | LAMATTINA JOHN L Director | Grant or award | +622 | 20,102 | ||
| 2016-05-23 | LAMATTINA JOHN L Director | Grant or award | +188 | 20,290 | ||
| 2016-05-23 | LAMATTINA JOHN L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,329 | $119.30 | $278K | 2,329 |
| 2016-05-23 | KOZARICH JOHN W Director | Grant or award | +622 | 44,333 | ||
| 2016-05-23 | KOZARICH JOHN W Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,329 | $119.30 | $278K | 2,329 |
| 2016-05-23 | Davis Todd C Director | Grant or award | +622 | 56,021 | ||
| 2016-05-23 | Davis Todd C Director | Grant or award | +188 | 56,209 | ||
| 2016-05-23 | Davis Todd C Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,329 | $119.30 | $278K | 2,329 |
| 2016-05-23 | Aryeh Jason Director | Grant or award | +622 | 58,959 |
Page 62 of 86 · 1,712 trades